Resultados de búsqueda - Ingrid Langsetmo

  • Mostrando 1 - 4 Resultados de 4
Limitar resultados
  1. 1
    HIF–prolyl hydroxylase inhibition results in endogenous erythropoietin induction, erythrocytosis, and modest fetal hemoglobin expression in rhesus macaques

    HIF–prolyl hydroxylase inhibition results in endogenous erythropoietin induction, erythrocytosis, and modest fetal hemoglobin expression in rhesus macaques por Matthew M. Hsieh, Nathaniel S. Linde, Aisha Wynter, Mark E. Metzger, Carol Wong, Ingrid Langsetmo, Al Lin, Reginald D. Smith, Griffin P. Rodgers, Robert E. Donahue, Stephen J. Klaus, John F. Tisdale

    Publicado 2007
    Enlace del recurso Enlace del recurso
    Artigo
    Agregar a favoritos
    Guardado en:
  2. 2
    Hypoxia-inducible Factor Prolyl 4-Hydroxylase Inhibition

    Hypoxia-inducible Factor Prolyl 4-Hydroxylase Inhibition por Ambreena Siddiq, Issam A. Ayoub, Juan C. Chávez, Leila R. Aminova, Sapan Shah, Joseph C. LaManna, Stephanie M. Patton, James R. Connor, Robert A. Cherny, Irene Volitakis, Ashley I. Bush, Ingrid Langsetmo, Todd Seeley, Volkmar Günzler, Rajiv R. Ratan

    Publicado 2005
    Enlace del recurso Enlace del recurso
    Artigo
    Agregar a favoritos
    Guardado en:
  3. 3
    Gastrointestinal Inhibition of Sodium-Hydrogen Exchanger 3 Reduces Phosphorus Absorption and Protects against Vascular Calcification in CKD

    Gastrointestinal Inhibition of Sodium-Hydrogen Exchanger 3 Reduces Phosphorus Absorption and Protects against Vascular Calcification in CKD por Eric D. Labonté, Christopher W. Carreras, Michael R. Leadbetter, Kenji Kozuka, Jill Kohler, Samantha Koo-McCoy, Limin He, Edward E. Dy, Deborah Black, Ziyang Zhong, Ingrid Langsetmo, Andrew Spencer, Noah Bell, Desiree Deshpande, Marc Navre, Jason G. Lewis, Jeffrey Jacobs, Dominique Charmot

    Publicado 2014
    Enlace del recurso
    Artigo
    Agregar a favoritos
    Guardado en:
  4. 4
    Nonclinical Characterization of the Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitor Roxadustat, a Novel Treatment of Anemia of Chronic Kidney Disease

    Nonclinical Characterization of the Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitor Roxadustat, a Novel Treatment of Anemia of Chronic Kidney Disease por Ughetta del Balzo, Pierre Signore, Gail Walkinshaw, Todd Seeley, Mitchell C. Brenner, Qingjian Wang, Guangjie Guo, Michael Arend, Lee A. Flippin, F. Aisha Chow, David C. Gervasi, Christian H. Kjaergaard, Ingrid Langsetmo, Volkmar Guenzler, David Y. Liu, S J Klaus, Al Lin, Thomas B. Neff

    Publicado 2020
    Enlace del recurso Enlace del recurso
    Artigo
    Agregar a favoritos
    Guardado en:

Herramientas de búsqueda: